ReflexMD is a telehealth service that connects adults with obesity to licensed clinicians who evaluate eligibility, prescribe FDA‑approved semaglutide and other GLP‑1 weight‑loss medications, and arrange direct‑to‑patient shipping. The platform includes a digital health dashboard, virtual follow‑ups, and personalized nutrition and activity guidance to help users manage dosage, track progress, and maintain adherence without in‑person visits.
Funding
Funding not disclosed
Founders
Product
Problem
Many individuals with obesity lack convenient access to clinically proven weight‑loss medications such as semaglutide and other GLP‑1 agonists, often requiring in‑person specialist visits and complex insurance navigation.
Solution
ReflexMD provides a telehealth platform that connects patients with qualified clinicians who evaluate eligibility, prescribe semaglutide or related GLP‑1 therapies, and coordinate medication delivery. The service integrates digital health assessments, remote monitoring, and personalized lifestyle guidance to support sustained weight loss. Patients receive ongoing virtual follow‑ups, dosage adjustments, and support resources without leaving their homes, streamlining the treatment pathway and improving adherence.
Target Audience
Primary customers are adults with obesity or overweight conditions seeking medically supervised, prescription‑based weight‑loss treatment through a convenient online platform.
Features
- Remote clinical evaluation and prescription of FDA‑approved semaglutide and other GLP‑1 agents
- Direct-to-patient medication shipping with pharmacy coordination
- Integrated digital health dashboard for tracking weight, dosage, and side effects
- Secure video consultations and messaging with licensed physicians
- Personalized nutrition and activity recommendations based on patient data
- Automated insurance verification and billing assistance